Engineering of near IR fluorescent albumin nanoparticles for in vivo detection of colon cancer

Journal of Nanobiotechnology

Volumn 10, Issue , 2012, Pages

  Cohen, Sarit ^a   Margel, Shlomo ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

Colon cancer; Fluorescent nanoparticles; HSA nanoparticles; NIR fluorescence; Optical imaging

Indexed keywords

ALBUMIN NANOPARTICLES; AUTOFLUORESCENCE; CANCER DRUG; CARBODIIMIDES; CARBOXYLIC ACID DERIVATIVES; COLON CANCER; COLONOSCOPY; DIAGNOSTIC TOOLS; DOXORUBICIN; FLUORESCENCE IMAGING; FLUORESCENT DYES; FLUORESCENT NANOPARTICLES; HUMAN SERUM ALBUMINS; IN-VIVO; MOUSE MODELS; NEAR-INFRARED FLUORESCENCE; NEAR-IR; NEOPLASM DETECTION; OPTICAL IMAGING; PACLITAXEL; PEANUT AGGLUTININ; PRECIPITATION PROCESS; SURFACE CARBOXYLATES; TUMOR DETECTION;

CARBOXYLATION; CARBOXYLIC ACIDS; DISEASES; DRUG THERAPY; IMAGING TECHNIQUES; INFRARED DEVICES; MONOCLONAL ANTIBODIES; NANOPARTICLES; ORGANIC POLYMERS; PHOTOBLEACHING; PRECIPITATION (CHEMICAL); SYNTHESIS (CHEMICAL); TUMORS; WATER ABSORPTION;

FLUORESCENCE;

ALBUMIN; ANTIBODY CONJUGATE; CARBOXYLIC ACID DERIVATIVE; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; CYANAMIDE; FLUORESCENT ALBUMIN NANOPARTICLE; FLUORESCENT DYE; HUMAN SERUM ALBUMIN; MONOCLONAL ANTIBODY; NANOPARTICLE; PEANUT AGGLUTININ; PEANUT AGGLUTININ MONOCLONAL ANTIBODY; TUMOR ASSOCIATED GLYCOPROTEIN 72 MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; BLEACHING; CANCER DIAGNOSIS; COLON CANCER; COLONOSCOPY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; FLUORESCENCE IMAGING; FLUORESCENT ANTIBODY TECHNIQUE; HISTOLOGY; HUMAN; HUMAN CELL; IMAGING SYSTEM; IN VIVO STUDY; INTESTINE FLUID; MOLECULAR STABILITY; MOUSE; NANOENCAPSULATION; NANOENGINEERING; NANOFABRICATION; NEAR INFRARED FLUORESCENCE IMAGING; NONHUMAN; PRECIPITATION; SCANNING ELECTRON MICROSCOPY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; CELL LINE, TUMOR; COLONIC NEOPLASMS; FLUORESCENT DYES; GLYCOPROTEINS; HISTOCYTOCHEMISTRY; HUMANS; INTESTINAL SECRETIONS; MATERIALS TESTING; MICE; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; NANOPARTICLES; PEANUT AGGLUTININ; SERUM ALBUMIN; TUMOR MARKERS, BIOLOGICAL;

ARACHIS HYPOGAEA;

EID: 84864961040     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/1477-3155-10-36     Document Type: Article

References (31)

1. Burt RW, Barthel JS, Dunn KB, David DS, Drelichman E, Ford JM, Giardiello FM, Gruber SB, Halverson AL, Hamilton SR. Colorectal cancer screening. J Natl Compr Canc Netw 2010, 8:8-61.
2. Nelson RS, Thorson AG. Colorectal cancer screening. Curr Oncol Rep 2009, 11:482-489. 10.1007/s11912-009-0065-8, 19840526.
3. Labianca R, Beretta GD, Mosconi S, Milesi L, Pessi MA. Colorectal cancer: screening. Ann Oncol 2005, 16:127-132.
4. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000, 343:1603-1607. 10.1056/NEJM200011303432203, 11096167.
5. Khullar O, Frangioni JV, Grinstaff M, Colson YL. Image-guided sentinel lymph node mapping and nanotechnology-based nodal treatment in lung cancer using invisible near-infrared fluorescent light. Thorac Cardiov Surg 2009, 21:309-315.
6. Jiang S, Gnanasammandhan MK, Zhang Y. Optical imaging-guided cancer therapy with fluorescent nanoparticles. J Roy Soc Interf 2009, 7:3-18.
7. Santra S, Dutta D, Walter GA, Moudgil BM. Fluorescent nanoparticle probes for cancer imaging. Technol Canc Res Treat 2005, 4:593-602.
8. Sharrna P, Brown S, Walter G, Santra S, Moudgil B. Nanoparticles for bioimaging. Adv Colloid Interf Sci 2006, 123:471-485.
9. Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Contr Release 2012, 157:168-182.
10. Taheri A, Dinarvand R, Ahadi F, Khorramizadeh MR, Atyabi F. The in vivo antitumor activity of LHRH targeted methotrexate-human serum albumin nanoparticles in 4 T1 tumor-bearing Balb/c mice. Int J Pharm 2012, 431:183-189. 10.1016/j.ijpharm.2012.04.033, 22531853.
11. Fasano M, Curry S, Terreno E, Galliano M, Fanali G, Narciso P, Notari S, Ascenzi P. The extraordinary ligand binding properties of human serum albumin. Iubmb Life 2005, 57:787-796. 10.1080/15216540500404093, 16393781.
12. Gekle M. Renal tubule albumin transport. Annual Review of Physiology 2005, 573-594. Annual Review of Physiology.
13. Harries M, Ellis P, Harper P. Nanoparticle albumin-bound paclitaxel for metastatic breast cancer. J Clin Oncol 2005, 23:7768-7771. 10.1200/JCO.2005.08.002, 16204007.
14. Petrelli F, Borgonovo K, Barni S. Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel. Expert Opin Pharmacother 2010, 11:1413-1432. 10.1517/14656561003796562, 20446855.
15. Williams RJ, Lipowska M, Patonay G, Strekowski L. Comparison of Covalent and Noncovalent Labeling with near-Infrared Dyes for the High-Performance Liquid-Chromatographic Determination of Human Serum-Albumin. Anal Chem 1993, 65:601-605. 10.1021/ac00053a019, 8452246.
16. Zhou JF, Chin MP, Schafer SA. Aggregation and degradation of indocyanine green. P Soc Photo-Opt Ins Bellingham 1994, 2128:495-505.
17. Horak D, Krystufek M, Spevacek J. Effect of reaction parameters on time dispersion polymerization of 1-vinyl-2-pyrrolidone. J Polym Sci Pol Chem 2000, 38:653-663.
18. Berezin MY, Lee H, Akers W, Nikiforovich G, Achilefu S. Ratiometric analysis of fluorescence lifetime for probing binding sites in albumin with near-infrared fluorescent molecular probes. Photochem Photobiol 2007, 83:1371-1378. 10.1111/j.1751-1097.2007.00173.x, 18028211.
19. Chen TS, Zeng SQ, Zhou W, Luo QM. A quantitative theory model of a photobleaching mechanism. Chin Phys Lett 2003, 20:1940-1943.
20. Sakuma S, Yano T, Masaoka Y, Kataoka M, Hiwatari K, Tachikawa H, Shoji Y, Kimura R, Ma H, Yang Z. In vitro/in vivo biorecognition of lectin-immobilized fluorescent nanospheres for human colorectal cancer cells. J Contr Release 2009, 134:2-10.
21. Zou P, Xu S, Povoski SP, Wang A, Johnson MA, Martin EW, Subramaniam V, Xu R, Sun D. Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. Mol Pharm 2009, 6:428-440. 10.1021/mp9000052, 2888669, 19718796.
22. Meyer T, Gaya AM, Dancey G, Stratford MRL, Othman S, Sharma SK, Wellsted D, Taylor NJ, Stirling JJ, Poupard L. A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomas. Clin Cancer Res 2009, 15:4484-4492. 10.1158/1078-0432.CCR-09-0035, 19549771.
23. Pedley RB, Boden J, Keep PA, Harwood PJ, Green AJ, Rogers GT. Relationship between Tumor Size and Uptake of Radiolabeled Anti-Cea in a Colon-Tumor Xenograft. Eur J Nucl Med 1987, 13:197-202.
24. Kantor J, Tran R, Greiner J, Pestka S, Fisher PB, Shively JE, Schlom J. Modulation of carcinoembryonic antigen messenger RNA Levels in human colon carcinoma cells by recombinant human γ-Interferon. Cancer Res 1989, 49:2651-2655.
25. Fang L, Battisti RF, Cheng H, Reigan P, Xin Y, Shen J, Ross D, Chan KK, Martin EW, Wang PG. Enzyme specific activation of benzoquinone ansamycin prodrugs using antibody-β-galactosidase conjugates. J Med Chem 2006, 49:6290-6297. 10.1021/jm060647f, 2596603, 17034135.
26. Bae S, Ma K, Kim TH, Lee ES, Oh KT, Park ES, Lee KC, Youn YS. Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types. Biomaterials 2012, 33:1536-1546. 10.1016/j.biomaterials.2011.10.050, 22118776.
27. Capdevila J, Elez E, Macarulla T, Ramos FJ, Ruiz-Echarri M, Tabernero J. Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment. Canc Treatm Rev 2009, 35:354-363.
28. Strekowski L, Mason CJ, Lee H, Gupta R, Sowell J, Patonay G. Synthesis of water-soluble near-infrared cyanine dyes functionalized with [(succinimido)oxy]carbonyl group. J Heterocycl Chem 2003, 40:913-916.
29. Langer K, Balthasar S, Vogel V, Dinauer N, von Briesen H, Schubert D. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm 2003, 257:169-180. 10.1016/S0378-5173(03)00134-0, 12711172.
30. Weber C, Coester C, Kreuter J, Langer K. Desolvation process and surface characterisation of protein nanoparticles. Int J Pharm 2000, 194:91-102. 10.1016/S0378-5173(99)00370-1, 10601688.
31. Corem-Salkmon E, Ram Z, Daniels D, Perlstein B, Last D, Salomon S, Tamar G, Shneor R, Guez D, Margel S. Convection-enhanced delivery of methotrexate-loaded maghemite nanoparticles. Int J Nanomed 2011, 6:1595.